Woman misdiagnosed with metastatic cancer takes legal action

A woman who was misdiagnosed with metastatic cancer and given a prognosis of only six months to live is now taking legal action against the Nicosia General Hospital and the Bank of Cyprus Oncology Center, as reported by Phileleftheros today. The details of the case are outlined in a letter from the woman's lawyer addressed to the Nicosia General Hospital and the Bank of Cyprus Oncology Centre, urging those responsible to provide explanations for the incident.

According to the article, the woman's suffering and the resulting consequences were a direct result of an erroneous biopsy result she received four months ago. Shockingly, she was informed that she had metastatic cancer with a life expectancy of six months and subsequently underwent a course of chemotherapy. However, upon re-examination of the biopsy sample, it was discovered that it actually belonged to another patient entirely.

In response to the incident, the Bank of Cyprus Oncology Centre acknowledges the receipt of the patient's letter, which presented evidence of receiving results meant for another individual. The center confirms that it has promptly initiated an investigation to verify the accuracy of the provided data.

Preliminary findings from the investigation indicate that, in principle, the patient in question did not receive any chemotherapy. The statement from the center emphasizes its commitment to treating these allegations with utmost sensitivity and diligence. They assure patients and their families that their primary goal, since the establishment of the center 25 years ago, has been to provide a high standard of care.

The center further states, "Once the internal investigation is completed and conclusions are drawn, all individuals directly involved will be duly informed." This case has sparked outrage and highlights the need for a thorough examination of the circumstances surrounding the misdiagnosis and subsequent treatment to prevent similar incidents from occurring in the future.